ESG Report

Overview

The report presents ADVANZ PHARMA's first ESG report for 2020/21, emphasizing its patient-focused purpose, social impact and governance foundations. It reports 556 employees, zero work-related fatalities, 30% female board representation and 991 Ton CO2eq of total Scope 1-3 emissions in 2020. The report also details charitable giving, diversity initiatives, ISO 37001 certification and location-based GHG accounting under the GHG Protocol. It outlines plans to reduce energy use and business travel and to achieve net zero by 2027.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2020-2021
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services